| Q35974913 | Activated Protein C Does Not Alleviate the Course of Systemic Inflammation in the APCAP Trial. |
| Q43917923 | Automatic detection of bacterial and fungal infections in blood |
| Q33719121 | Bacterial infection and extent of necrosis are determinants of organ failure in patients with acute necrotizing pancreatitis |
| Q37450352 | Biomarkers: a definite plus in pneumonia |
| Q52859823 | Calcitonin Precursors: Early Markers of Gut Barrier Dysfunction in Patients With Acute Pancreatitis |
| Q34339611 | Calcitonin: physiological actions and clinical applications |
| Q35552565 | Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? |
| Q36235416 | Clinical value of severity markers in acute pancreatitis |
| Q24198268 | De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock |
| Q24235566 | De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock |
| Q73193288 | Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini Consensus Conference |
| Q40826137 | Diagnostic relevance of procalcitonin, IL-6, and sICAM-1 in the prediction of infected necrosis in acute pancreatitis |
| Q34086518 | Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis |
| Q55042362 | Does serum procalcitonin have a role in evaluating the severity of acute pancreatitis? A question revisited. |
| Q55043783 | Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): a prospective international multicenter study. |
| Q38240877 | Early phase of acute pancreatitis: Assessment and management |
| Q38660305 | Early prediction of infected pancreatic necrosis secondary to necrotizing pancreatitis |
| Q73906897 | Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study |
| Q77621119 | Effect of carboxamide derivative IS-741 on rat spontaneous chronic pancreatitis |
| Q51673442 | Factors Predicting Mortality in Severe Acute Pancreatitis |
| Q40597069 | Fever and solid tumor: diagnostic value of procalcitonin and C-reactive protein |
| Q34628768 | Forty years of calcitonin--where are we now? A tribute to the work of Iain Macintyre, FRS. |
| Q33673787 | Gastrointestinal complications in the intensive care unit |
| Q35134545 | Gastrointestinal disorders of the critically ill. Shock and acute pancreatitis |
| Q27691380 | Immunomodulatory therapies for acute pancreatitis |
| Q80307216 | Immunosuppression in patients with severe acute pancreatitis |
| Q35361584 | Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications |
| Q55004912 | Inflammatory mediators in the diagnosis and treatment of acute pancreatitis: pentraxin-3, procalcitonin and myeloperoxidase. |
| Q36235396 | Inflammatory response on the pancreatic acinar cell injury |
| Q41196827 | Interleukin-6: An Early Predictive Marker for Severity of Acute Pancreatitis |
| Q40337728 | Is procalcitonin a marker of invasive bacterial infection in acute sickle-cell vaso-occlusive crisis? |
| Q30795206 | Isolation and characterization of serum procalcitonin from patients with sepsis |
| Q74671844 | Katacalcin and calcitonin immunoreactivity in different types of leukocytes indicate intracellular procalcitonin content |
| Q33727381 | Leucocyte activation markers in clinical practice |
| Q57474159 | Levels of the chemokines growth-related oncogene alpha and epithelial neutrophil-activating protein 78 are raised in patients with severe acute pancreatitis |
| Q40882347 | Lipopolysaccharide directly affects pancreatic acinar cells: implications on acute pancreatitis pathophysiology |
| Q34512097 | Management of necrotizing pancreatitis |
| Q35055026 | Markers of inflammation in sepsis |
| Q61757056 | Meta-analysis of procalcitonin for sepsis detection |
| Q59167784 | Meta-analysis of procalcitonin for sepsis detection – Authors' reply |
| Q42379928 | Monitoring procalcitonin is of value in acute pancreatitis |
| Q47595427 | Multicenter evaluation of a new immunoassay for procalcitonin measurement on the Kryptor System |
| Q92704863 | Multifactorial Scores and Biomarkers of Prognosis of Acute Pancreatitis: Applications to Research and Practice |
| Q34303687 | New approaches to sepsis: molecular diagnostics and biomarkers. |
| Q34634636 | New laboratory tests in acute pancreatitis |
| Q34297910 | New serum markers for the detection of severe acute pancreatitis in humans. |
| Q36993196 | Novel biomarkers to detect infection in revision hip and knee arthroplasties |
| Q34756556 | Pathobiochemistry and clinical use of procalcitonin |
| Q37625516 | Pathogenic mechanisms of pancreatitis |
| Q38840155 | Pathophysiological mechanisms in acute pancreatitis: Current understanding |
| Q27027755 | Pathophysiology of acute pancreatitis: potential application from experimental models and human medicine to dogs |
| Q42630269 | Percutaneous necrosectomy and sinus tract endoscopy in the management of infected pancreatic necrosis: an initial experience. |
| Q42022638 | Planned staged reoperative necrosectomy using an abdominal zipper in the treatment of necrotizing pancreatitis |
| Q36785154 | Predicting severity of acute pancreatitis |
| Q79299181 | Predictive value of complement activation fragments C3a and sC5b‐9 for development of severe disease in patients with acute pancreatitis |
| Q38087919 | Predictors of adverse outcomes in acute pancreatitis: new horizons |
| Q36162369 | Prevention of infectious complications in severe acute pancreatitis with systemic antibiotics: where are we now? |
| Q81251179 | Procalcitonin (PCT) is useful in predicting the bacterial origin of an acute circulatory failure in critically ill patients |
| Q38736343 | Procalcitonin Strip Test as an Independent Predictor in Acute Pancreatitis |
| Q24800762 | Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction |
| Q58314283 | Procalcitonin and acute coronary syndromes: a new biomarker for an old disease |
| Q40584674 | Procalcitonin and neopterin as indicators of infection in critically ill patients |
| Q37663041 | Procalcitonin as a biomarker of bacterial infection in sickle cell vaso-occlusive crisis |
| Q34750152 | Procalcitonin as a marker of sepsis |
| Q85642986 | Procalcitonin as a marker of sepsis in alcoholic hepatitis |
| Q83225219 | Procalcitonin as an early predictor of postoperative infectious complications in patients with acute traumatic spinal cord injury |
| Q77989632 | Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro |
| Q40609219 | Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II. |
| Q41679971 | Procalcitonin--a new indicator of the systemic response to severe infections |
| Q40419462 | Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancer |
| Q38197674 | Prognostic markers in acute pancreatitis. |
| Q33637252 | Prophylactic antibiotics for severe acute pancreatitis: the beginning of an era. |
| Q40627510 | Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: the potential importance of bacterial translocation |
| Q33642578 | Rapid diagnostic methods in the detection of sepsis |
| Q34551241 | Review of feline pancreatitis part two: clinical signs, diagnosis and treatment |
| Q37028474 | Role of biomarkers in the management of antibiotic therapy: an expert panel review II: clinical use of biomarkers for initiation or discontinuation of antibiotic therapy |
| Q35358768 | Role of procalcitonin and granulocyte colony stimulating factor in the early prediction of infected necrosis in severe acute pancreatitis |
| Q44528526 | Role of procalcitonin in infectious gastroenteritis and inflammatory bowel disease |
| Q38107378 | Scoring of human acute pancreatitis: state of the art. |
| Q44176290 | Selective inhibition of NF-kappaB attenuates the severity of cerulein-induced acute pancreatitis |
| Q38826374 | Serum C-reactive protein, procalcitonin, and lactate dehydrogenase for the diagnosis of pancreatic necrosis. |
| Q57010154 | Serum amyloid A, procalcitonin, and C-reactive protein in early assessment of severity of acute pancreatitis |
| Q50995257 | Serum procalcitonin differentiates inflammatory bowel disease and self-limited colitis. |
| Q40346600 | Serum procalcitonin does not differentiate between infection and disease flare in patients with systemic lupus erythematosus |
| Q33433721 | Serum procalcitonin for the early recognition of nosocomial infection in the critically ill patients: a preliminary report |
| Q57922334 | Serum procalcitonin levels can be used to differentiate between inflammatory and non-inflammatory diarrhea in acute infectious diarrhea |
| Q35913456 | Serum procalcitonin: Early detection of neonatal bacteremia and septicemia in a tertiary healthcare facility |
| Q38363178 | Serum value of procalcitonin as a marker of intestinal damages: type, extension, and prognosis |
| Q42550331 | Severe acute pancreatitis: Clinical course and management |
| Q37060412 | Severe acute pancreatitis: pathogenetic aspects and prognostic factors |
| Q34012616 | Soluble CD40 ligand in prediction of acute severe pancreatitis |
| Q43978427 | Soluble triggering receptor expressed on myeloid cells in severe acute pancreatitis: a biological marker of infected necrosis |
| Q46925385 | Surgical management and complex treatment of infected pancreatic necrosis: 18-year experience at a single center |
| Q41166500 | The importance of determining procalcitonin and C reactive protein in different stages of sepsis |
| Q37119332 | The role of serum procalcitonin levels in predicting ascitic fluid infection in hospitalized cirrhotic and non-cirrhotic patients |
| Q35130657 | The usefulness of laboratory tests in the early assessment of severity of acute pancreatitis |
| Q35128138 | Useful Markers for Predicting Severity and Monitoring Progression of Acute Pancreatitis |
| Q74610266 | [Procalcitonin: a new marker of bacterial infection. Importance and prospects] |
| Q35787857 | alpha2-macroglobulin- and murinoglobulin-1- deficient mice. A mouse model for acute pancreatitis |